SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-008846
Filing Date
2021-04-13
Accepted
2021-04-14 11:07:35
Documents
14
Period of Report
2021-04-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20210408_8k.htm   iXBRL 8-K 38200
2 EXHIBIT 3.1 ex_239832.htm EX-3.1 103226
  Complete submission text file 0001437749-21-008846.txt   308144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210407.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210407_def.xml EX-101.DEF 12361
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210407_lab.xml EX-101.LAB 16564
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210407_pre.xml EX-101.PRE 12625
7 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210408_8k_htm.xml XML 2777
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 21824869
SIC: 2836 Biological Products, (No Diagnostic Substances)